""Ultimately it is FDA, not this Court, that possesses the expertise to evaluate scientific evidence and make public health judgments," writes Joseph, a Trump appointee."
""We're seeing a kind of civil war between Republicans about how quickly and how far to go that the Louisiana case exemplifies," says Mary Ziegler, legal history professor."
""In asking for the stay, Trump's FDA also signaled that it would be taking a harder line against mifepristone, possibly reversing some of what Biden's FDA did to maximize access to telehealth abortion.""
A federal judge in Louisiana ruled that access to mifepristone, an abortion drug, will remain unchanged while the FDA reviews its safety. The ruling does not endorse telehealth abortion, which accounts for over 25% of U.S. abortions. Judge David C. Joseph emphasized that the FDA has the expertise to evaluate scientific evidence. He granted a stay for the case, allowing the FDA six months to update the court on its safety review. The ruling reflects a divide among Republicans regarding abortion policies and the complexities surrounding the Trump administration's stance.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]